3Garcia MJ, McNamara PM, Gordon T, KannelWB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105-11.
4Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602.
5Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, et al. Attenuatior by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coil Cardiol 2006; 48: 1688-97.
6Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med 2006; 41: 851-61.
7Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003; 108: 754-9.
8Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784-9.
9Wold LE, Ren J. Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase- dependent oxidative stress mechanism. Biochem Biophys Res Commun 2004; 318: 1066-71.
10Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemiainduced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002; 51: 1938-48.
2WANG Jun1,2, BAI Ling1,2, LI Jing3, SUN ChaoFeng1,2, ZHAO Jin1, CUI ChangCong1,2, HAN Ke1,2, LIU Yu1,2, ZHUO XiaoZhen1,2, WANG TingZhong1,2, LIU Ping1,2, FAN FenLing1,2, GUAN YouFei3 & MA AiQun1,2 1 Department of Cardiology, First affiliated hospital of medical college of Xi’an Jiaotong University, Xi’an 710061, China,2 Ion Channel Disease Laboratory, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry, Xi’an 710061, China,3 Department of Physiology and Pathophysiology,Key Laboratory of Molecular Cardiovascular Sciences of the Ministry of Education, Peking University Health Science Center, Beijing 100083, China.Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart[J].Science China(Life Sciences),2009,52(11):1003-1010. 被引量：11
3Schiller AM,Pellegrino PR,Zucker IH.The renal nerves in chronic heart failure:efferent and afferent mechanisms[J].Front Physiol,2015,6:224.
4Qavi AH,Kamal R,Schrier RW.Clinical Use of Diuretics in Heart Failure,Cirrhosis,and Nephrotic Syndrome[J].Int J Nephrol,2015,2015:975934.
5Goldwater DS,Pinney SP.Frailty in Advanced Heart Failure:A Consequence of Aging or a Separate Entity[J].Clin Med Insights Cardiol,2015,9(Suppl 2):39-46.
6Kern T,Kedan I,Kimchi A.Natriuretic Peptides and the Management of Heart Failure[J].Rev Cardiovasc Med,2015,16(2):95-104.
7Li JK,Atlas G.Left Ventricle-Arterial System Interaction in Heart Failure[J].Clin Med Insights Cardiol,2015,9(Suppl 1):93-9.
8Lyons OD,Bradley TD.Heart Failure and Sleep Apnea[J].Can J Cardiol,2015,31(7):898-908.
